Dyne Therapeutics Inc (DYN) Return on Assets ROA from the third quarter of 2026 to third quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Dyne Therapeutics Inc   (NASDAQ: DYN)


Dyne Therapeutics Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Dyne Therapeutics Inc 's ROA in the third quarter of 2026?
Dyne Therapeutics Inc recorded a cumulative net loss of $-605 million during 12 months ending in the third quarter of 2026, resulting in a negative return on assets (ROA) of -53.82%.

However, within the Healthcare sector 567 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 3918, from total ROA ranking in the second quarter of 2026 at 4632.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Total Assets Change 42.41 % 36.35 % 49.77 % 78.58 % 16.97 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -605 -519 -452 -446 -424
Return On Assets (TTM) -53.82 % -50.33 % -46.77 % -50.94 % -56.85 %
DYN's Total Ranking # 3918 # 4632 # 4124 # 4177 # 4167
Total Assets (TTM) in million 1,235 994 1,080 1,187 867
Seq. Total Assets Change 24.22 % -7.96 % -9.02 % 36.89 % 18.94 %
Seq. Net Income Change - - - - -

DYN's 5 Years Annual ROA >> Back to DYN Management Effectiveness >> Compare DYN ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 247
Sector # 568
Overall # 3921

Return On Assets Statistics
High Average Low
108.01 %
-15.22 %
-103.66 %
(Mar 31 2021)   (Dec 31 2023)





Financial Statements
Dyne Therapeutics Inc 's Assets $ 1,235 million DYN's Balance sheet
Dyne Therapeutics Inc 's Income $ -194 million Quarterly DYN's Income Statement
DYN's Income by Division See DYN's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 73.11 % 395.45 % -50.59 % -29.85 % 9.55 %
Total Assets in million 1,151 665 134 272 387
Y / Y Net Income Change - - - - -
Net Income in million -446 -317 -236 -168 -149
Annual Return On Assets -38.78 % -47.76 % -175.87 % -61.91 % -38.57 %

DYN's 5 Years Annual ROA >> Back to DYN Management Effectiveness >> Compare DYN ROA to its Competitors



More Return On Assets Ratios
DYN's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
DYN's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for DYN's Competitors
Subscribers only: Roa for Dyne Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for DYN's Customers

You may also want to know
DYN's Roi DYN's Inventory Turnover Ratio DYN's Growth Rates DYN's Dividend Comparisons
DYN's Profitability Ratios DYN's Asset Turnover Ratio DYN's Dividend Growth
DYN's Roe DYN's Valuation Ratios DYN's Financial Strength Ratios DYN's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector ROA

Date modified: 2026-11-06T05:39:41+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.